REVIEW
Accepted on 21 Jan 2025
A Comprehensive Review of Schisandrin B's Preclinical Antitumor Activity and Mechanistic Insights from Network Pharmacology
doi 10.3389/fphar.2025.1528533
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Reviews in Pharmacology of Anti-Cancer Drugs: 2023
Reviews in Pharmacology of Anti-Cancer Drugs: 2023
1,551
Total downloads
6,377
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Accepted on 08 Jan 2025
A Review on Intrathecal Administration of Medications for Leptomeningeal Metastases in Solid Tumors
doi 10.3389/fphar.2025.1472945
ORIGINAL RESEARCH
Accepted on 07 Jan 2025
A Pharmacoinformatic Approach for Studying Atractylodes Lancea DC's Anticancer Potential and Control ROS-Mediated Apoptosis Against Prostate Cancer Cells
doi 10.3389/fonc.2025.1471110
REVIEW
Published on 04 Dec 2024
Recent advances in cell membrane-coated porphyrin-based nanoscale MOFs for enhanced photodynamic therapy
doi 10.3389/fphar.2024.1505212
- 355 views
REVIEW
Published on 09 Oct 2024
From defense to offense: antimicrobial peptides as promising therapeutics for cancer
doi 10.3389/fonc.2024.1463088
- 1,154 views
REVIEW
Published on 01 Oct 2024
RGD-based self-assembling nanodrugs for improved tumor therapy
doi 10.3389/fphar.2024.1477409
- 839 views
REVIEW
Published on 27 Sep 2024
Diversified applications of hepatocellular carcinoma medications: molecular-targeted, immunotherapeutic, and combined approaches
doi 10.3389/fphar.2024.1422033
- 637 views
ORIGINAL RESEARCH
Published on 26 Jul 2024
A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases
doi 10.3389/fphar.2024.1374136
- 900 views
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 6,377Topic views
- 3,494Article views
- 1,551Article downloads